Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 14.57%144.97M | 0.20%269.57M | -3.24%126.54M | 84.06%269.02M | 113.38%130.78M | 13.54%146.16M | -3.31%61.29M | 25.09%128.73M | 53.90%63.39M | -51.12%102.91M |
| Operating income | 14.57%144.97M | 0.20%269.57M | -3.24%126.54M | 84.06%269.02M | 113.38%130.78M | 13.54%146.16M | -3.31%61.29M | 25.09%128.73M | 53.90%63.39M | -51.12%102.91M |
| Cost of sales | -12.12%-18.16M | -5.16%-36.52M | 5.35%-16.19M | -39.34%-34.73M | -68.14%-17.11M | -5.70%-24.92M | 6.58%-10.18M | -28.91%-23.58M | -45.67%-10.89M | 39.80%-18.29M |
| Operating expenses | -12.12%-18.16M | -5.16%-36.52M | 5.35%-16.19M | -39.34%-34.73M | -68.14%-17.11M | -5.70%-24.92M | 6.58%-10.18M | -28.91%-23.58M | -45.67%-10.89M | 39.80%-18.29M |
| Gross profit | 14.93%126.82M | -0.53%233.05M | -2.93%110.35M | 93.26%234.29M | 122.38%113.68M | 15.30%121.23M | -2.63%51.12M | 24.26%105.15M | 55.73%52.5M | -53.03%84.62M |
| Selling expenses | -11.24%-87.28M | -3.68%-165.33M | -2.89%-78.46M | -75.53%-159.45M | -93.89%-76.26M | -12.15%-90.84M | -0.42%-39.33M | -10.02%-81M | -27.34%-39.17M | 47.10%-73.62M |
| Administrative expenses | -15.07%-18.7M | 2.77%-34.49M | 2.33%-16.25M | -9.39%-35.47M | -16.88%-16.64M | -10.47%-32.42M | -2.81%-14.23M | -22.26%-29.35M | -29.87%-13.85M | 15.67%-24.01M |
| Special items of operating profit | 54.46%1.33M | 220.71%886K | 184.69%863K | -119.56%-734K | -145.96%-1.02M | 46.56%3.75M | 200.00%2.22M | -84.97%2.56M | -93.34%739K | 529.97%17.03M |
| Operating profit | 34.39%22.18M | -11.70%34.12M | -16.50%16.5M | 2,136.28%38.64M | 8,691.74%19.76M | 165.45%1.73M | -200.88%-230K | -165.70%-2.64M | -93.26%228K | -73.60%4.02M |
| Financing cost | 12.10%-494K | -5.25%-1.18M | -11.73%-562K | -97.89%-1.12M | -147.78%-503K | -74.23%-568K | -14.69%-203K | 40.07%-326K | 43.63%-177K | 30.88%-544K |
| Earning before tax | 36.02%21.68M | -12.21%32.94M | -17.23%15.94M | 3,134.40%37.52M | 4,547.58%19.26M | 139.11%1.16M | -949.02%-433K | -185.38%-2.97M | -98.34%51K | -75.93%3.47M |
| Tax | -40.00%-3.78M | 26.56%-5.03M | 33.90%-2.7M | -932.43%-6.85M | -6,107.35%-4.09M | -131.23%-663K | 126.15%68K | 473.78%2.12M | 0.38%-260K | 115.51%370K |
| After-tax profit from continuing operations | 35.21%17.9M | -9.01%27.91M | -12.75%13.24M | 6,071.83%30.67M | 4,256.99%15.17M | 158.96%497K | -74.64%-365K | -121.93%-843K | -107.44%-209K | -68.09%3.84M |
| Earning after tax | 35.21%17.9M | -9.01%27.91M | -12.75%13.24M | 6,071.83%30.67M | 4,256.99%15.17M | 158.96%497K | -74.64%-365K | -121.93%-843K | -107.44%-209K | -68.09%3.84M |
| Profit attributable to shareholders | 35.21%17.9M | -9.01%27.91M | -12.75%13.24M | 6,071.83%30.67M | 4,256.99%15.17M | 158.96%497K | -74.64%-365K | -121.93%-843K | -107.44%-209K | -68.09%3.84M |
| Basic earnings per share | 35.06%0.0235 | -9.18%0.0366 | -12.56%0.0174 | 5,657.14%0.0403 | 4,080.00%0.0199 | 163.64%0.0007 | -66.67%-0.0005 | -122.00%-0.0011 | -108.11%-0.0003 | -68.75%0.005 |
| Diluted earnings per share | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Jiuan (Hong Kong) Certified Public Accountants Limited | -- | Huarong (Hong Kong) Certified Public Accountants Limited | -- | Huarong (Hong Kong) Certified Public Accountants Limited | -- | Huarong (Hong Kong) Certified Public Accountants Limited | -- | Huilian Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.